Vasodilatory effects of glucagon: A possible new approach to enhanced subcutaneous insulin absorption in artificial pancreas devices
Patients with diabetes mellitus type 1 depend on exogenous insulin to keep their blood glucose concentrations within the desired range. Subcutaneous bihormonal artificial pancreas devices that can measure glucose concentrations continuously and autonomously calculate and deliver insulin and glucagon...
| Autors principals: | , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Frontiers Media S.A.
2022-09-01
|
| Col·lecció: | Frontiers in Bioengineering and Biotechnology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.986858/full |